Day: October 5, 2020

The 2 Coronavirus Vaccine Stocks I’d Buy Right Now

It’s too early to say which company — or companies — will win the coronavirus vaccine race. But we do have tools to identify the most promising players. It’s important to look at timelines, clinical trial data, and a company’s ability to fund and manufacture billions of doses of a safe and effective vaccine. More of this information is available now than was the case a few months ago.

Considering these elements, Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) would be on my buy list. The clinical-stage biotech and big pharma player are among the 11 programs currently in phase 3 trials. Both are working on messenger RNA (mRNA) vaccines. Unlike traditional vaccines, they don’t introduce weakened virus into the body. Instead, they instruct the body to make specific disease antigens to fight future infection. Let’s take a closer look at both companies to see exactly what makes them the best coronavirus

Read More

Apple Fitness Plus comes after Peloton with streaming workouts that sync with Apple Watch

apple-event-apple-watch-15.png

Apple/Screenshot by CNET

This story is part of Apple Event, our full coverage of the latest news from Apple headquarters.

Apple on Tuesday announced Apple Fitness Plus, a fitness streaming subscription that gives you guided workouts using the workout metrics from your Apple Watch. The service is similar to Peloton Digital and other fitness streaming services out there, but this is the first that’s been built explicitly for the Apple Watch

Here’s how it works: You pick any workout video from the Fitness Plus app on your iPad, iPhone or Apple TV and start it. Your Apple Watch syncs your heart rate, calories burned, pace and duration data to Fitness Plus. You can then see that data on whichever screen you’re using to follow the workout. During some workouts, you’ll get onscreen cues to ramp up your pace or heart rate to push yourself.

The service costs $9.99

Read More

Researchers test antibody drug as treatment for COVID-19 | News Center

Stanford Medicine researchers are investigating whether a combination of specific antibodies can reduce early symptoms of COVID-19 in people with mild to moderate cases of the disease.

Their effort is part of a multisite clinical trial of an antibody drug developed by Eli Lilly and AbCellera that aims to enroll 550 participants at hospitals and medical centers nationwide. 

Andra Blomkalns, MD, principal investigator of the Stanford trial site, said she hopes to enroll 20 to 40 participants who have tested positive for COVID-19 at Stanford Health Care’s Marc and Laura Andreessen Emergency Department. 

“The goal is to see if we can get sick people better faster, reducing both the length of their illness and how long they are shedding the virus, and therefore help prevent others from getting sick,” said Blomkalns, professor and chair of emergency medicine. “I think this treatment shows great promise.”

It’s a Phase II trial, which

Read More

Dentist who extracted tooth on hoverboard gets 12 years

An Alaska dentist who extracted a patient’s tooth while riding on a hoverboard has been sentenced to 12 years behind bars for that stunt and other wheel-y bad crimes.

Seth Lookhart was sentenced Monday in Anchorage Superior Court on dozens of charges that stemmed from actions that ranged from his scooting antics to Medicaid fraud and removing a patient’s teeth without their permission, the Anchorage Daily News reported.

He was convicted back in January on charges of reckless endangerment, illegally practicing dentistry and medical assistance fraud.

“In reviewing all this over and over again, I have this visceral response — you darn near killed some people,” Judge Michael Wolverton said in handing down the sentence.

Seth Lookhart
Seth Lookhart on the hoverboard during the procedure

The court heard testimony at his trial from patient Veronica Wilhelm, who was sedated when he was recorded performing her tooth extraction on a hoverboard in July

Read More

Trump, stricken by COVID-19, flown to military hospital

WASHINGTON (AP) — Stricken by COVID-19, a feverish and fatigued President Donald Trump was flown to a military hospital Friday night after being injected with an experimental drug combination in treatment at the White House.



President Donald Trump gives a thumbs-up as he leaves the White House to go to Walter Reed National Military Medical Center after he tested positive for COVID-19, Friday, Oct. 2, 2020, in Washington. (AP Photo/Alex Brandon)


© Provided by Associated Press
President Donald Trump gives a thumbs-up as he leaves the White House to go to Walter Reed National Military Medical Center after he tested positive for COVID-19, Friday, Oct. 2, 2020, in Washington. (AP Photo/Alex Brandon)

In a day of whipsaw events, the president who has spent months downplaying the threat of the virus was forced to cancel all campaign events a month before the election as he fought a virus that has killed more than 205,000 Americans and is hitting others in his orbit as well.

The White House said Trump’s expected stay of “a few days” at Walter Reed National Military Medical Center was precautionary and that he

Read More